Introduction
Low Dose Naltrexone (LDN) is one of the most remarkable and underutilized tools in integrative medicine. At a fraction of its standard dose, this decades-old, inexpensive medication produces powerful anti-inflammatory and immune-modulating effects that have demonstrated clinical benefit across a remarkable range of conditions — from autoimmune diseases and chronic pain to neurological conditions, cancer support, and post-infectious illness.
Despite a growing body of clinical evidence and an exceptional safety profile, LDN remains largely unknown to mainstream medicine. This guide provides everything you need to know: how LDN works, what conditions it helps, how to find a prescriber, what to expect when starting, and how to optimize your protocol.
For a broader overview of repurposed drugs including LDN, see our How Repurposed Drugs Work guide.
Part I: What Is LDN & How Does It Work?
Naltrexone at Standard Doses
Naltrexone is an FDA-approved opioid receptor antagonist used at 50mg/day to treat opioid use disorder and alcohol dependence. At this dose, it completely blocks opioid receptors for 24 hours. It has been used safely since 1984.
The Low Dose Difference
At 1.5–4.5mg/day — roughly 1/10th of the standard dose — naltrexone produces entirely different effects. Instead of sustained opioid receptor blockade, LDN produces a brief (4–6 hour) transient blockade, typically during sleep when taken at bedtime. This brief blockade triggers a compensatory rebound that is the foundation of LDN’s therapeutic effects.
LDN’s Three Core Mechanisms
1. Endorphin Rebound
When LDN transiently blocks opioid receptors, the body responds by producing more endorphins and upregulating opioid receptor sensitivity. This endorphin surge — which occurs during the day when LDN has worn off — has profound immune-modulating, anti-inflammatory, and mood-enhancing effects. Endorphins are critical regulators of immune function, pain modulation, and cellular health.
2. TLR4 Antagonism & Microglial Suppression
LDN blocks Toll-like receptor 4 (TLR4) on microglia (the brain’s immune cells) and peripheral macrophages, directly suppressing neuroinflammation and systemic inflammatory cytokine production (TNF-α, IL-6, IL-1β). This is LDN’s most important anti-inflammatory mechanism and explains its broad therapeutic applicability across virtually every chronic inflammatory condition.
3. OGF/OGFr Axis Modulation
LDN transiently blocks the opioid growth factor receptor (OGFr), triggering upregulation of endogenous opioid growth factor (met-enkephalin / OGF). OGF has direct anti-proliferative effects — inhibiting cell division in cancer cells and overactive immune cells — making this mechanism particularly relevant in cancer support and autoimmune conditions.
Part II: What Conditions Does LDN Help?
Autoimmune Diseases
LDN’s immune-modulating effects — reducing Th17 overactivation, promoting Treg function, and suppressing inflammatory cytokines — are directly relevant to autoimmune pathology. Clinical evidence supports LDN in multiple sclerosis, Crohn’s disease (clinical trials demonstrating remission induction and mucosal healing), ulcerative colitis, rheumatoid arthritis, lupus, psoriasis, and Hashimoto’s thyroiditis. See our Autoimmune Disease article for detail.
Fibromyalgia & Chronic Pain
Stanford University clinical trials demonstrated significant reductions in pain scores, fatigue, and cognitive symptoms with LDN 4.5mg/day in fibromyalgia. Its mechanisms — microglial suppression reducing central sensitization and endorphin upregulation enhancing descending pain inhibition — directly address fibromyalgia’s neurobiological drivers. See our Chronic Pain & Fibromyalgia article for detail.
Neurological & Mental Health
LDN’s microglial suppression and neuroinflammation reduction are relevant across depression, anxiety, ADHD, and early neurodegeneration. See our Neurological Health article for detail.
Cancer Support
LDN’s OGF/OGFr anti-proliferative mechanism, NK cell and cytotoxic T-cell enhancement, and tumor microenvironment modulation make it a valuable adjunct in integrative oncology. See our Oncology & Cellular Health article for detail.
Post-Infectious Conditions
LDN’s TLR4 antagonism addresses the persistent neuroinflammation driving Long COVID, post-Lyme disease syndrome, and ME-CFS. See our Infectious & Post-Infectious Disease article for detail.
Gut Conditions
Beyond Crohn’s, LDN demonstrates visceral analgesic effects in IBS and mucosal immune modulation in IBD. See our Gut & Microbiome Health article for detail.
Part III: The Evidence Base
- Randomized controlled trials — Crohn’s disease (pediatric and adult), fibromyalgia (Stanford), MS, complex regional pain syndrome
- Open-label trials and pilot studies — across autoimmune conditions, cancer, ME-CFS, and neurological conditions
- Large observational studies — the LDN Research Trust patient registry documents outcomes across thousands of patients
- Extensive case reports — particularly in cancer and rare autoimmune conditions
- Mechanistic research — robust preclinical evidence supporting TLR4 antagonism, microglial suppression, and OGF/OGFr modulation
Part IV: How to Get LDN
Step 1: Find a Prescriber
LDN requires a prescription from a licensed physician. Options include:
- Functional medicine physicians — use the IFM practitioner directory at ifm.org/find-a-practitioner
- Naturopathic doctors (NDs) — in states where NDs have prescribing authority
- Integrative medicine physicians — ABOIM-certified practitioners
- Telehealth platforms — several services specialize in LDN prescribing; search “LDN telehealth” for current options
- Your existing physician — bringing published research (Stanford fibromyalgia trials, Crohn’s disease trials) can facilitate the conversation
Step 2: Get It Compounded
Standard naltrexone tablets are 50mg — far too high for LDN. LDN must be prepared by a compounding pharmacy in the required low doses (1.5mg, 3mg, or 4.5mg capsules, or as a liquid for precise titration). Cost is typically $30–60/month.
Step 3: Liquid vs. Capsule
- Capsules — convenient, consistent dosing; most common form
- Liquid (1mg/mL solution) — allows precise dose titration in very small increments; preferred for sensitive individuals starting at very low doses (0.5mg)
Part V: Starting LDN — What to Expect
Starting Dose & Titration
- Week 1–2: 1.5mg at bedtime
- Week 3–4: 3.0mg at bedtime (if well-tolerated)
- Week 5+: 4.5mg at bedtime (most commonly used therapeutic dose)
Some sensitive individuals start at 0.5mg and titrate more slowly. There is no universal optimal dose — some people respond better at 3mg than 4.5mg.
Timing
LDN is almost always taken at bedtime (9pm–12am), aligning the transient receptor blockade with sleep so the endorphin rebound occurs during the day.
Common Initial Side Effects
- Vivid dreams or nightmares — most common side effect; occurs in ~30–40% of new users; typically resolves within 2–4 weeks; if persistent, try taking LDN earlier in the evening or reducing dose temporarily
- Mild sleep disturbance — related to the above; usually transient
- Mild nausea — uncommon; taking with a small amount of food can help
- Temporary symptom flare — some experience a brief worsening in the first 1–2 weeks as the immune system recalibrates; this typically resolves and is not a reason to stop
How Long Until It Works?
Most people require 4–12 weeks of consistent use before noticing significant benefit. Autoimmune diseases may require 3–6 months for full therapeutic effect. Patience and consistency are essential — do not judge LDN’s efficacy in the first few weeks.
Contraindications
- Current opioid use — LDN will precipitate opioid withdrawal; opioids must be stopped for at least 7–10 days before starting LDN
- Significant liver disease — use with caution and monitoring
- Pregnancy — safety not established; discuss with your provider
- Immunosuppressant medications — discuss potential interactions with your prescriber
Part VI: Optimizing Your LDN Protocol
Synergistic Combinations
- LDN + CBD — complementary anti-neuroinflammatory and immune-modulating effects
- LDN + anti-inflammatory diet — dietary inflammation reduction amplifies LDN’s effects
- LDN + gut restoration — reducing gut dysbiosis lowers the systemic inflammatory burden LDN is working against
- LDN + curcumin and omega-3s — complementary NF-κB and cytokine suppression
See our Supplement Stacking Guide for comprehensive combination guidance.
Monitoring
Baseline and periodic liver function tests (LFTs) are recommended, particularly in the first 6 months. Beyond this, LDN requires minimal monitoring for most patients.
Long-Term Use
LDN is safe for long-term use. Unlike immunosuppressant medications, LDN modulates and normalizes immune function rather than suppressing it, making long-term use appropriate for chronic conditions.
Patient Resources
- LDN Research Trust — ldnresearchtrust.org — research database, patient forum, and prescriber directory
- LDN Science — ldnscience.org — evidence-based information for patients and practitioners
- The LDN Book (Volumes 1 & 2) — edited by Linda Elsegood; comprehensive patient and practitioner guides
This article is for educational purposes only and does not constitute medical advice. LDN is a prescription medication that should only be used under the supervision of a qualified healthcare provider. See our Educational Standards & Medical Disclaimer for full details.
0 comments